Publications by authors named "Siqin Gaowa"

Objective: The purpose of this study was to observe the relationship between objectively measured levels of physical activity and cognitive impairment (CI) in the presence or absence of diabetes in middle-aged and elderly hemodialysis patients.

Methods: In this multicenter cross-sectional study, 339 clinically stable hemodialysis patients (210 males; mean age: 67.38 ± 8.

View Article and Find Full Text PDF

Objective: To evaluate the psychometric properties of the Union Physio-Psycho-Social Assessment Questionnaire (UPPSAQ-70) among general hospital psychiatric outpatients.

Methods: A total of 2000 participants responded to the survey. Factor analyses were used to test the construct validity of the scale.

View Article and Find Full Text PDF
Article Synopsis
  • A phase III clinical trial was conducted to evaluate the effects of different radiation doses (high vs. standard) and irradiation fields (involved field vs. elective nodal) on survival outcomes for patients with locally advanced esophageal squamous cell carcinoma (ESCC).
  • Results indicated that there were no significant differences in overall survival (OS) or progression-free survival (PFS) between the different irradiation fields, but the high-dose treatment suggested an improvement in PFS compared to the standard dose.
  • The best prognostic outcomes were observed in the high-dose with involved field group (HD+IFI), while the standard dose with involved field group (SD+IFI) had the worst outcomes, and no substantial differences in severe adverse events were
View Article and Find Full Text PDF

Objectives: Cardiac rehabilitation (CR) improves outcomes after myocardial infarction (MI), but it is underused in China. The purpose of this study was to develop a set of quality indicators (QIs) to improve clinical practices and to confirm the measurability and performance of the developed QIs for CR in Chinese patients after MI.

Design And Setting: The QIs were developed by a Chinese expert consensus panel during in-person meetings.

View Article and Find Full Text PDF

Mitochondria-eating protein (Mieap) plays a critical role in mitochondrial quality control (MQC) and functions as a p53-inducible tumor suppressor. This study aimed to examine its role in gastric cancer (GC) and esophageal cancer (EC). GC cells were infected with Mieap-overexpressing adenovirus (Ad-Mieap) and subjected to fluorescence-activated cell sorting (FACS), western blotting, and caspase assays.

View Article and Find Full Text PDF

Mitochondria-eating protein (Mieap), encoded by a p53-target gene, plays an important role in mitochondrial quality control (MQC). Mieap has been reported to have a critical role in tumor suppression in colorectal cancer. Here, we investigated its role as a tumor suppressor in breast cancer.

View Article and Find Full Text PDF

Glycoprotein non-metastatic B (GPNMB), a type I transmembrane glycoprotein, is overexpressed in melanoma and breast cancer and promotes cancer-cell invasion and motility. We previously reported cross-talk between GPNMB and human epidermal growth factor receptor 2 (HER2) in breast cancer, suggesting that GPNMB might play an important role in resistance to anti-HER2 therapy in breast cancer. Here, we clarified the association between GPNMB and HER-family proteins in gastrointestinal cancer by examining their relationships using gastric and colorectal cancer cell lines.

View Article and Find Full Text PDF

Targeted molecular therapy is an effective anticancer strategy. Anti-EGFR monoclonal antibodies such as cetuximab (CTX) have been approved for the treatment of various malignancies, including colorectal cancer (CRC) with wild-type KRAS. However, their efficacy in patients with KRAS mutations has not been established.

View Article and Find Full Text PDF
Article Synopsis
  • Glycoprotein nonmetastatic B (GPNMB) has been identified as a potential oncogene, especially in melanoma and breast cancer (BC), and is linked to higher levels in BC patients compared to colorectal and gastric cancer patients.
  • A study measured serum GPNMB levels in 162 BC patients and found it significantly elevated in HER2-rich subtypes, suggesting it could be a useful biomarker for this type of cancer.
  • Further experiments showed that depleting GPNMB increased HER2 expression, indicating that GPNMB interacts with the HER2 signaling pathway, which may have implications for anti-HER2 therapies like trastuzumab.
View Article and Find Full Text PDF